|

Gemcitabine+Albumin-bound paclitaxel Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 2

Top Sponsors

  • Zhejiang University1
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

  • Cancer2
  • Advanced Pancreatic Cancers1
  • Pancreatic Adenocarcinoma1

Other2 trials

Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer
Phase 2
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.